Abretone Abiraterone 250 Mg Tablets

Product Description

Introduction

Abretone 250mg Tablet contains the active ingredient Abiraterone Acetate and is prescribed for the treatment of prostate cancer in adult men, particularly when the disease has spread to other parts of the body. This medication works by lowering androgen (male hormone) levels in the body, slowing the progression of cancer and improving overall survival. It is often given along with a corticosteroid to reduce the risk of side effects such as fluid retention or hypertension.

When used in the early stages of the disease, ABRETONE 250MG TABLET dosage for prostate cancer is typically combined with testosterone-lowering therapy for enhanced effectiveness. Patients must strictly follow their doctoris instructions regarding dosage and timing, as self-adjusting the treatment may reduce its benefits or cause complications.

Effective Prostate Cancer Treatment

Abretone Abiraterone 250 mg Tablets are specifically recommended for adult male patients with metastatic castration-resistant prostate cancer. Its active ingredient, Abiraterone Acetate, works by inhibiting androgen production, helping to slow cancer progression and improve patient outcomes. Consultation with a qualified oncologist is required for safe administration.


Safe Usage and Administration Guidelines

These tablets are meant for oral consumption and should be taken at least one hour before or two hours after meals to ensure optimal absorption. The standard dosage is typically 1,000 mg (four tablets) once daily, but always follow your physician's instructions. Appropriate storage-below 30C, away from light and moisture-preserves the medicine's efficacy.


Comprehensive Packaging for Convenience

Each box contains a bottle of 120 tablets, offering a month's supply at common dosage patterns. The physical form and secure packaging help maintain product integrity, while clear labelling ensures you receive authentic medication. This product is marketed across India by RPG Life Sciences Limited.